Covered recipient · General Payments record
FLORENCE P TOMASIC
Nursing Service Providers Registered Nurse
General Payments · PY2021–2023
$1,630.27
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $236.50 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.44 | 2 |
| ABBVIE INC. | $58.39 | 2 |
| Abbott Laboratories | $37.87 | 2 |
| Novo Nordisk AS | $32.45 | 2 |
| GlaxoSmithKline, LLC. | $20.64 | 1 |
| PFIZER INC. | $17.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.70 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051278955 | CMS |
| Abbott Laboratories | $23.17 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051278951 | CMS |
| ABBVIE INC. | $19.30 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010044863 | CMS |
| ABBVIE INC. | $39.09 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010044867 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.76 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996945231 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.68 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996945227 | CMS |
| GlaxoSmithKline, LLC. | $20.64 | 05/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003880877 | CMS |
| Novo Nordisk Inc | $13.07 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000895041 | CMS |
| Novo Nordisk Inc | $19.38 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000895058 | CMS |
| PFIZER INC. | $17.71 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050290117 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.